Presatovir (GS-5806) is an antiviral drug which was developed as a treatment for respiratory syncytial virus.[1][2] It acts as a fusion inhibitor, and has shown promising results in Phase II clinical trials.[3][4]
Clinical data | |
---|---|
Trade names | Presatovir |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
Chemical and physical data | |
Formula | C24H30ClN7O3S |
Molar mass | 532.06 g·mol−1 |
3D model (JSmol) | |
| |
|